Key result
Postsystolic myocardial augmentation successfully reversed cardiac dilatation, elevated end-diastolic pressures, and arterial hypotension in experimental heart failure.
Why the study?
Does postsystolic myocardial augmentation improve hemodynamics in experimental heart failure?
Does postsystolic myocardial augmentation improve hemodynamics in experimental heart failure?
This early experimental study demonstrates the physiological feasibility of postsystolic myocardial augmentation to reverse hemodynamic compromise in heart failure.
Should not yet influence clinical heart failure management; leaves open further exploration in prospective studies.
Technique and appropriate equipment are reported which remove blood from the circulation during cardiac systole, thereby reducing intraventricular systolic blood pressure and the work of systolic ejection. Blood is reinjected during ventricular diastole, so that the diastolic blood pressure and coronary blood flow are increased. An electronic circuit enables the phasing of the augmenting systole to be placed accurately in relationship to the QRS complex of the EKG. Application of the technique to experimental heart failure induced by norepinephrine and hemorrhage is illustrated. Cardiac dilatation, elevated end-diastolic pressures, and arterial hypotension are reversed by the use of this technique. In addition, it is possible to supply an unlimited quantity of oxygenated, banked, standard venous blood to the ascending aorta via intra-arterial cannulas. The technique which we have developed overcomes difficulties previously experienced by those who wished to withdraw blood during systole and reinject it during diastole. The size of the pump is adequate to change the blood pressure effectively; the timing of reinjection is such as to accomplish reinjection during the short period of ventricular diastole. Submitted on May 8, 1961
No takes yet. Share an insight, caveat, or question.
Watkins et al. (1962) studied Experimental heart failure. Postsystolic myocardial augmentation was evaluated on Reversal of cardiac dilatation, elevated end-diastolic pressures, and arterial hypotension. Postsystolic myocardial augmentation successfully reversed cardiac dilatation, elevated end-diastolic pressures, and arterial hypotension in experimental heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: